Mrs. Sherri Jones Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 141 Twin Lake Rd, Gaffney, SC 29341 Phone: 864-206-2201 Fax: 864-902-3541 |
News Archive
SwitchGear Genomics, Inc., a leading provider of products for studying regulatory elements in the human genome, today announced the launch of a unique research tool for screening for miRNA function in living cells. The new SwitchGear GoCloneâ„¢ miRNA target sets utilize experimentally-validated luciferase reporter vectors to accurately quantify human 3'UTR activity in response to a number of relevant miRNAs.
Detailed analysis of genes expressed in circulating tumor cells (CTCs) - cells that break off from solid tumors and travel through the bloodstream - has identified a potential treatment target in metastatic pancreatic cancer.
Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy.
When individuals suffer a spinal cord injury, paralysis is only a part of the major impact on quality of life. Often they also lose bladder control, which frequently causes infections that can lead to kidney damage.
Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of "digital proteomics" with next generation sequencers. One of the nation's top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.
› Verified 1 days ago